Write your message
Volume 7, Issue 4 (July & August 2022)                   J Obstet Gynecol Cancer Res 2022, 7(4): 279-285 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Allameh T, Kalatehjari M. The Values of Colposcopy in Patients with the Diagnosis of the High-Grade Squamous Intraepithelial Lesion in Routine Papanicolaou Test. J Obstet Gynecol Cancer Res. 2022; 7 (4) :279-285
URL: http://jogcr.com/article-1-470-en.html
1- Department of Obstetrics and gynecology, Isfahan University of Medical Sciences, Isfahan, Iran
2- Department of Obstetrics and gynecology, Isfahan University of Medical Sciences, Isfahan, Iran , mk.medicine@yahoo.com
Full-Text [PDF 267 kb]   (74 Downloads)     |   Abstract (HTML)  (665 Views)
Full-Text:   (56 Views)

Cervical cancer is the second most common cancer of females worldwide that affects 530000 new cases annually and causes death in over 270000 females each year (1). This malignancy is remarkable for developing countries as about 80% of the deaths due to cervical cancer are reported in these countries (2).
On the other hand, this cancer is one of the most preventable ones that can be diagnosed in early curable stages. The Papanicolaou test (Pap smear) is the most cost-effective and conventional means for screening and probably early cervical cancer diagnosis (3). In cases presenting abnormal pop smear, colposcopy and endocervical curettage or biopsy may be required to confirm the diagnosis (4, 5).
Considering the remarkable high rate of hetero-genicity in the Pap smear capability of correct diagnosis with the high rate of false-negative reports in up to 49% of the cases, there is no unified about the most efficient means for the most accurate early diagnosis of cervical cancer (5).
Although limited studies are presenting acceptable and more accurate outcomes of colposcopy in contrast to Pap smear, their supporting data are still conflicting as there are studies showing discordance of colposcopy findings with the definite histological diagnosis through biopsy (6-9).
In the current study, we have aimed to assess colposcopy values in contrast to the histological findings of the cervix biopsies among females with Pap smears suspected for cervical cancer.


Materials and Methods

The current report is a cross-sectional study conducted on 94 patients diagnosed with the high-grade squamous intraepithelial lesion (HSIL) in Pap smear referred to Shahid-Beheshti Hospital affiliated at Isfahan University of Medical Sciences, Iran, from December 2016 to December 2018.
All patients diagnosed with HSIL based on the findings of Pap smear who have undergone both colposcopy and histological study through biopsy were included. Those who presented their unwillingness to participate in the study and patients who had impaired records of either colposcopy or histology were excluded.
The Ethics Committee of Isfahan University of Medical Sciences approved the study protocol (ethical code: IR.MUI.MED.REC.1397.312). After that, all of the study-associated required information was provided to the study participants, and they were reassured about the confidentiality of their data. The participants were requested to sign a written form of participation in this study.
The patients were initially examined macro-scopically by vaginal examination. Also, a convent-ional Pap smear test was performed for all patients 8 weeks after the first Pap smear. The Bethesda scale was the basis for interpreting the samples. Based on the diagnosis of HSIL in the Pap smear, the colposcopy was performed for the patients by a skilled target gynecologist. The colposcopies were done using either acetic acid 5% or iodine solution 12%. The transitional squamous, columnar zone detection was considered the satisfactory colposcopy (10). The presence of aceto-white lesions with vascular and/or epithelial lesions was considered as positive colposcopy. The colposcopic findings were normal, with chronic cervicitis, the thin acetowhite lesion (AWL), dense/thick AWL, AVP, pilling, and cauliflower-like mass.
Biopsies were taken from all patients and interpreted by a target skilled pathologist to minimize the potential inter-observer bias. The biopsies were presented as normal, cervicitis, atypical squamous cells of undeter-mined significance (ASCUS), cervical intraepithelial neoplasia-1, -2 or -3 (CIN-1, -2 or -3), carcinoma-in-situ (CIS), adenocarcinoma and invasive squamous cell carcinoma (SCC). The results of the biopsies were regarded as the gold standard, and then the colposcopy findings were compared accordingly. Besides, the findings of conventional Pap-smear were compared with biopsy as well. Human papillomavirus (HPV) was not assessed through laboratory tests, and only the pathologic changes contributed to the HPV contami-nation found through biopsies were reported as the HPV positivity.
The obtained data were entered into the SPSS (SPSS Inc., Chicago, IL., USA) version 20 and analyzed. The descriptive data were presented in mean and percen-tages. ROC curves and the area under the curve (AUC) were measured for analytics. Sensitivity, specificity, positive predictive value (PPV), and negative predi-ctive value (NPV) were measured. A P-value of less than 0.05 was considered as a significant level.



The study population had a mean age of 41.67±11.42 years (range: 21-81 years) and a mean age of 20.04±4.21 years at the marriage time (range: 13-35 years). The mean number of giving birth was 2.72±1.99 (range: 0-8).
Among the study population, sixty-seven (71.2%) of the patients did not use contraceptives. Further inform-ation about the type of contraception is presented in Table 1. Thirty-seven (39.4%) of the patients required no further intervention while 22 (23.4%) underwent conization biopsy; among them, eight (8.51%) required a transabdominal hysterectomy, and five (5.31%) with the worst biopsy reports underwent a radical hysterectomy.

Table 1. Demographic information of the study population

Age (mean± SD) 41.67±11.42
Age at marriage (mean± SD) 20.04±4.21
Number of giving birth (mean± SD) 2.72±1.99
Contraception (%) Nothing 67 (71.2%)
Withdrawal 6 (6.4%)
Oral contraceptive 5 (5.3%)
Tube ligation 7 (7.4%)
Barrier 6 (6.4%)
Vasectomy 3 (3.2%)

Biopsy findings were normal, LSIL (CIN 1, 2), HSIL (CIN 3 or CIS) and invasive carcinoma in 51 (54.2%), 16 (17.02%), 22 (23.4%) and 5 (5.3%) cases respectively. Based on Table2, the pap-smear results were significantly in accordance with the biopsy reports (P<0.001). Based on Table 2, the kappa coefficient index was 0.225.
The findings, including normal, thin AWL, thick AWL, and AVP/pilling/cauliflower lesions, were found in 22 (23.4%), 38 (40.42%), 26 (27.65%), and 8 (8.51%) colposcopies, respectively. Table 2 represents biopsy and colposcopy results in detail. Based on Table 2, significant concordance was found between colposcopy and biopsy with a P-value of <0.001 and a kappa coefficient index of 0.247.

Table 2. Kappa coefficient assessments based on pap-smear*biopsy, colposcopy*biopsy

  Pap-smear Total
Normal LSIL/
HSIL Invasive carcinoma
Biopsy Normal 42 1 8 0 51
LSIL 6 2 7 1 16
HSIL 9 5 8 0 22
Invasive carcinoma 1 1 2 1 5
  58 9 25 2 94
Normal Thin AWL Thick AWL AVP/pilling + caul-flower lesion Total
Biopsy Normal 21 21 5 4 51
LSIL 0 7 7 4 16
HSIL 1 9 12 0 22
Invasive carcinoma 0 1 2 2 5
  22 38 26 8 94
    Normal Abnormal  
Biopsy Normal 21 30 51
Abnormal 1 42 43
  Total 22 72 94

Based on the findings above, the colposcopy could statistically diagnose normal, CIN-1 and invasive SCC/adenocarcinoma/AVP/cauliflower lesion and pilling cases (P<0.05) but was not significantly in association with the correct diagnosis of CIN-2, -3 and CIS (P>0.79). Based on Table 3, the sensitivity and specificity of colposcopy for the diagnosis of normal cases were 82% and 60%, for CIN-1 were 56% and 68% and for invasive SCC/adenocarcinoma/AVP/-cauliflower lesion and pilling (cancerous lesions) were 80% and 66%, respectively. Based on the last part of Table 3, colposcopy's total sensitivity and specificity based on the biopsy findings as the gold standard were 97% and 41%, respectively. This assessment revealed a statistically significant association (P<0.001) with a kappa index of 0.369.

Table 3. Sensitivity, specificity, positive/negative likelihood ratio and area under curve based on the diagnoses of colposcopy

Colposcopy Index  
82% Sensitivity Normal &/or cervicitis
60% Specificity
2.05 Positive likelihood ratio
0.3 Negative likelihood ratio
0.764 AUC (CI 95%)
<0.001 P-value
56% Sensitivity CIN-1 (Thin AWL)
68% Specificity
1.75 Positive likelihood ratio
0.64 Negative likelihood ratio
0.676 AUC (CI 95%)
0.028 P-value
57% Sensitivity CIN-2 & -3 & CIS
(Thick AWL)
69% Specificity
1.83 Positive likelihood ratio
0.62 Negative likelihood ratio
0.643 AUC (CI 95%)
0.761 P-value
80% Sensitivity Invasive SCC or adenocarcinoma, AVP cauliflower lesion & pilling
66% Specificity
2.35 Positive likelihood ratio
0.30 Negative likelihood ratio
0.793 AUC (CI 95%)
0.028 P-value
97% Sensitivity Total values for colposcopy
41% Specificity
58% Positive predictive value
95% Negative predictive value
<0.001 P-value



The required time for the progression of precan-cerous lesions of the cervix to the incurable malignant masses can clarify the necessity of using an appropriate means with the highest accuracy to make an on-time definite diagnosis (11).
Studies in the literature have shown that Pap smear as the most popular screening test is not reliable enough to make the diagnosis and further therapeutic approaches (12, 13). In the current study, we observed the remarkable concordance of Pap-smear with the biopsy reports (P<0.001, kappa=0.225). Contrary to our study, Lonky et al. conducted a study presenting a low non-significant correlation of Pap-smear with cytology findings presenting high-grade dysplasia, while it had higher sensitivity and specificity for the correct diagnosis of malignant lesions (14). Other studies represented better outcomes of Pap-smear with the sensitivity of 34-57% and specificity of 85-97% for the correct diagnosis of high-grade intraepithelial lesions and malignant ones. In general, studies are unanimous about the ability of Pap-smear for the correct diagnosis of malignant lesions. However, the matter is about the early diagnosis to prevent progressed masses (15, 16). We think the high specificity presented by mentioned studies is mostly attributed to detecting malignant lesions but LSIL or HSIL. Surprisingly, a study in China presented a high sensitivity rate of 85%, again for detecting non-benign lesions; malignant ones are included (17).
This study tried to assess the accuracy of colposcopy for the correct diagnosis of cervical lesions based on biopsy as the gold standard. Our findings represented that colposcopy was in statistical concordance with the findings obtained from biopsies (P<0.001; kappa-=0.247). Furthermore, a remarkable association was found for the correct diagnosis of normal, CIN-1, and cancerous lesions. The highest sensitivity was detected for normal/cervicitis diagnosis (82%), followed by cancerous lesions (80%) and then CIN-1 (56%). Hence, the most significant specificity was found for CIN-1 (68%), followed by lesions representing cancer (66%) and normal/cervicitis (60%). In general, the colposcopy study of the cervix represented the notable sensitivity of 97% and specificity of 41%.
Colposcopy for the early diagnosis of cervical lesions has been assessed for a long time in the litera-ture, but the reports are confusingly controversial. An old study by Maiman et al. presented inferior findings than ours, reporting the sensitivity and specificity of 80% and 29% in general. It was 83% and 27% respectively for high-grade lesions (18).
A pilot study by McAdam et al. on 496 females declared the specificity of 77% and sensitivity of 99% for colposcopy assessments of CIN-2 or worse conditions (19). We have not found the remarkable capability of colposcopy for the proper early diagnosis of CIN-2, -3, and CIS lesions.
The other study by Sayyah-Melli was conducted on 315 patients. Similar to this study, they considered histological findings as the gold standard and presented sensitivity and specificity of 90.3% and 90.9%, respectively (20). Their outcomes regarding colpo-scopy ability in the correct diagnosis of cervical lesions were surprisingly higher than ours.
The other study performed by Karimi et al. in Yazd presented 80% of both sensitivity and specificity for colposcopy for the early diagnosis of precancerous lesions in the cervix (21).
Karimi-Zarchi et al. designed their study to compare colposcopy with other Pap smear and cytology techniques. They eventually presented 70.9% of sensitivity and 44.4% of specificity for colposcopy. Similar to this study, they presented a statistical association of colposcopy with cytology findings (11).
Remarkable differences in the studies about the ability of colposcopy in the correct detection of non-benign cervical lesions may be attributed to the operator skill, quality of colposcopy performance and interpretation, and the classification of the lesions.
Other studies in this term have unanimously presented the superiority of colposcopy over Pap smear while the values of this technique for correct diagnosis were diverse (3, 22, 23). In this term, further studies are recommended.



remarkably in concordance with histological reports. Furthermore, the colposcopic interpretations were significantly sensitive and specific for diagnosing both non-malignant CIN-1 and malignant cervical lesions. On the other hand, colposcopy assessments could not statistically diagnose CIN-2, -3, and CIS lesions correctly based on histological reports showing a notable limitation in diagnosing precancerous HISL. Further evaluations are strongly recommended.



We would like to thank all the researchers and care providers for the early diagnosis and treatment of gynecological cancers to prevent mortality and morbidity in women. This study has been approved in the Department of Obstetrics and Gynecology of Isfahan University of Medical Sciences.


Conflicts of Interest

The authors declared no conflicts of interest.


Statement of Ethics

The patient had signed the informed consent to report the present article.

Systematic Review: Original Research | Subject: Obstetrics and Gynecology
Received: 2021/08/16 | Accepted: 2021/10/23 | Published: 2022/03/14

1. McGraw SL, Ferrante JM. Update on prevention and screening of cervical cancer. World J Clin Oncol. 2014;5(4):744-52. [DOI:10.5306/wjco.v5.i4.744] [PMID] [PMCID]
2. Bueno CT, Silva CMDd, Barcellos RB, Silva Jd, Santos CRd, Menezes JES, et al. Association between cervical lesion grade and micronucleus frequency in the Papanicolaou test. Genet Mol Biol. 2014;37(3):496-9. [DOI:10.1590/S1415-47572014000400004] [PMID] [PMCID]
3. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22(12):2675-86. [DOI:10.1093/annonc/mdr015] [PMID]
4. Barut MU, Kale A, Kuyumcuoglu U, Bozkurt M, Agacayak E, Ozekinci S, et al. Analysis of Sensitivity, Specificity, and Positive and Negative Predictive Values of Smear and Colposcopy in Diagnosis of Premalignant and Malignant Cervical Lesions. Med Sci Monit. 2015;21:3860-7. [DOI:10.12659/MSM.895227] [PMID] [PMCID]
5. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, et al. Cervical Cancer, Version 2.2015. J Natl Compr Canc Netw. 2015;13(4):395-404; quiz [DOI:10.6004/jnccn.2015.0055] [PMID]
6. Pandey K, Bhagoliwal A, Jain S. Optical Imaging: Future Tool in Detection of Precancerous and Cancerous Lesions of Cervix and Its Comparison to Colposcopy. J Obstet Gynaecol India. 2015;65(3):176-80. [DOI:10.1007/s13224-014-0511-x] [PMID] [PMCID]
7. Giannella L. The clinical problem of colposcopy is represented by false-negatives. Arch Gynecol Obstet. 2015;291(4):711-2. [DOI:10.1007/s00404-015-3619-z] [PMID]
8. Sakano CR, Ribalta JC, Zucchi P. Tracking of cervical cancer in 7,519 patients: a study of the prevalence of altered cytologies. Eur J Gynaecol Oncol. 2015;36(4):437-41.
9. Mayeaux Jr EJ, Harper MB, Abreo F, Pope JB, Phillips GS. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology. J Family Pract. 1995;40(1):57-63.
10. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol. 2001;82(3):516-22. [DOI:10.1006/gyno.2001.6323] [PMID]
11. Karimi-Zarchi M, Peighmbari F, Karimi N, Rohi M, Chiti Z. A Comparison of 3 Ways of Conventional Pap Smear, Liquid-Based Cytology and Colposcopy vs Cervical Biopsy for Early Diagnosis of Premalignant Lesions or Cervical Cancer in Women with Abnormal Conventional Pap Test. Int J Biomed Sci. 2013;9(4):205-10.
12. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327(18):1272-8. [DOI:10.1056/NEJM199210293271804] [PMID]
13. McKee MD, Lurio J, Marantz P, Burton W, Mulvihill M. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center. Arch Fam Med. 1999;8(2):129-34. [DOI:10.1001/archfami.8.2.129] [PMID]
14. Lonky NM, Sadeghi M, Tsadik GW, Petitti D. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynecol. 1999;181(3):560-6. [DOI:10.1016/S0002-9378(99)70493-X]
15. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119(5):1095-101. [DOI:10.1002/ijc.21955] [PMID]
16. Farzaneh F, Tamimi M, Amiri Z, Alizadeh K. The value of Pap smear in detecting cervical neoplasia compared with histopathologic findings in patients referred to Taleghani Hospital, Tehran 2007-2009. 2011.
17. Moy LM, Zhao FH, Li LY, Ma JF, Zhang QM, Chen F, et al. Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: comparison of sensitivity, specificity, and frequency of referral. Int J Cancer. 2010;127(3):646-56. [DOI:10.1002/ijc.25071] [PMID]
18. Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD, et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol. 1998;68(3):233-9. [DOI:10.1006/gyno.1998.4938] [PMID]
19. McAdam M, Sakita J, Tarivonda L, Pang J, Frazer IH. Evaluation of a cervical cancer screening program based on HPV testing and LLETZ excision in a low resource setting. PloS one. 2010;5(10):e13266. [DOI:10.1371/journal.pone.0013266] [PMID] [PMCID]
20. Sayyah-Melli M, Rahmani V, Ouladsahebmadarek E, Jafari-Shobeiri M, Gharabaghi PM, Vahidi MN. Diagnostic Value of Pap Smear and Colposcopy in Non-benign Cervical Lesions. morbidity mortality. 2017;2:4. [DOI:10.15296/ijwhr.2019.35]
21. Zarchi MK, Binesh F, Kazemi Z, Teimoori S, Soltani HR. Value of Colposcopy in the Early Diagnosis of Cervical Cancer in Abnormal Pap Smears in Patients Referred to the Gynecology-Oncology Clinic at Shahid Sadoughi Hospital, Yazd. Asian Pac J Cancer Prevent. 2011;12:3439-41.
22. Ghaem Maghami F, Ensani F, Behtash N, Hosseini Nejad S. Histologic findings of uterine cervix among women with cytologic diagnosis of ASCUS (atypical squamous cells of undetermined significance). Tehran Univ Med J. 2004;62(4):326-31.
23. Matsuura Y, Kawagoe T, Toki N, Sugihara K, Kashimura M. Early cervical neoplasia confirmed by conization: diagnostic accuracy of cytology, colposcopy and punch biopsy. Acta Cytol. 1996;40(2):241-6. [DOI:10.1159/000333745] [PMID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.